Sera Capital Surpluse vs Net Working Capital Analysis

SERA Stock

USD 6.74 0.12 1.81%

Sera Prognostics financial indicator trend analysis is much more than just breaking down Sera Prognostics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sera Prognostics is a good investment. Please check the relationship between Sera Prognostics Capital Surpluse and its Net Working Capital accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sera Prognostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.

Capital Surpluse vs Net Working Capital

Capital Surpluse vs Net Working Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sera Prognostics Capital Surpluse account and Net Working Capital. At this time, the significance of the direction appears to have very week relationship.

The correlation between Sera Prognostics' Capital Surpluse and Net Working Capital is 0.25. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Net Working Capital in the same time period over historical financial statements of Sera Prognostics, assuming nothing else is changed. The correlation between historical values of Sera Prognostics' Capital Surpluse and Net Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of Sera Prognostics are associated (or correlated) with its Net Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Working Capital has no effect on the direction of Capital Surpluse i.e., Sera Prognostics' Capital Surpluse and Net Working Capital go up and down completely randomly.

Correlation Coefficient

0.25

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Capital Surpluse

Net Working Capital

Most indicators from Sera Prognostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sera Prognostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sera Prognostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.As of December 1, 2024, Selling General Administrative is expected to decline to about 12.8 M. In addition to that, Issuance Of Capital Stock is expected to decline to 1,092

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	659K	1.2M	900K	1.1M
Interest Income	145K	456K	1.6M	1.7M

Depreciation And Amortization Interest Income

Sera Prognostics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab
Total Assets		-0.98	0.87	0.62	0.99	-0.79	0.97	0.69	0.6	-0.63	-0.78	0.89	0.41	0.97	0.49	0.91	-0.79	0.98	0.71	0.37	-0.96	0.63	-0.39	0.89	0.95	-0.97
Short Long Term Debt Total	-0.98		-0.89	-0.74	-0.99	0.86	-0.98	-0.73	-0.7	0.51	0.85	-0.84	-0.27	-0.99	-0.44	-0.96	0.86	-0.94	-0.79	-0.42	0.98	-0.67	0.48	-0.84	-0.98	0.98
Other Current Liab	0.87	-0.89		0.66	0.87	-0.95	0.85	0.5	0.57	-0.48	-0.76	0.71	0.27	0.84	0.55	0.87	-0.96	0.86	0.65	0.39	-0.86	0.62	-0.37	0.78	0.92	-0.86
Total Current Liabilities	0.62	-0.74	0.66		0.69	-0.81	0.75	0.81	0.88	0.14	-0.9	0.55	-0.37	0.76	0.34	0.87	-0.8	0.48	0.88	0.43	-0.78	0.81	-0.63	0.29	0.83	-0.74
Total Stockholder Equity	0.99	-0.99	0.87	0.69		-0.82	0.99	0.75	0.7	-0.52	-0.85	0.89	0.28	0.98	0.48	0.92	-0.82	0.96	0.8	0.48	-0.99	0.68	-0.51	0.85	0.96	-1.0
Other Liab	-0.79	0.86	-0.95	-0.81	-0.82		-0.83	-0.53	-0.72	0.24	0.85	-0.59	-0.01	-0.82	-0.4	-0.89	1.0	-0.73	-0.76	-0.49	0.84	-0.63	0.53	-0.65	-0.92	0.83
Net Tangible Assets	0.97	-0.98	0.85	0.75	0.99	-0.83		0.78	0.78	-0.42	-0.91	0.86	0.17	0.98	0.42	0.92	-0.83	0.92	0.87	0.56	-1.0	0.69	-0.61	0.8	0.96	-1.0
Property Plant And Equipment Net	0.69	-0.73	0.5	0.81	0.75	-0.53	0.78		0.78	-0.03	-0.82	0.83	-0.17	0.75	0.58	0.77	-0.53	0.6	0.82	0.38	-0.8	0.91	-0.51	0.31	0.75	-0.79
Current Deferred Revenue	0.6	-0.7	0.57	0.88	0.7	-0.72	0.78	0.78		0.23	-0.96	0.55	-0.48	0.71	0.18	0.73	-0.71	0.48	0.99	0.78	-0.8	0.7	-0.91	0.31	0.74	-0.76
Net Debt	-0.63	0.51	-0.48	0.14	-0.52	0.24	-0.42	-0.03	0.23		0.01	-0.51	-0.97	-0.49	-0.31	-0.37	0.25	-0.73	0.09	0.25	0.38	0.01	-0.35	-0.82	-0.41	0.45
Retained Earnings	-0.78	0.85	-0.76	-0.9	-0.85	0.85	-0.91	-0.82	-0.96	0.01		-0.72	0.25	-0.84	-0.37	-0.86	0.84	-0.68	-0.99	-0.73	0.92	-0.79	0.81	-0.51	-0.88	0.89
Accounts Payable	0.89	-0.84	0.71	0.55	0.89	-0.59	0.86	0.83	0.55	-0.51	-0.72		0.31	0.82	0.74	0.77	-0.59	0.89	0.66	0.35	-0.87	0.8	-0.33	0.66	0.82	-0.89
Cash	0.41	-0.27	0.27	-0.37	0.28	-0.01	0.17	-0.17	-0.48	-0.97	0.25	0.31		0.25	0.22	0.13	-0.02	0.53	-0.34	-0.43	-0.13	-0.2	0.55	0.66	0.17	-0.2
Non Current Assets Total	0.97	-0.99	0.84	0.76	0.98	-0.82	0.98	0.75	0.71	-0.49	-0.84	0.82	0.25		0.38	0.96	-0.82	0.91	0.8	0.39	-0.97	0.65	-0.49	0.82	0.97	-0.98
Non Currrent Assets Other	0.49	-0.44	0.55	0.34	0.48	-0.4	0.42	0.58	0.18	-0.31	-0.37	0.74	0.22	0.38		0.47	-0.4	0.52	0.26	-0.01	-0.46	0.79	0.1	0.23	0.51	-0.47
Other Assets	0.91	-0.96	0.87	0.87	0.92	-0.89	0.92	0.77	0.73	-0.37	-0.86	0.77	0.13	0.96	0.47		-0.89	0.83	0.8	0.31	-0.93	0.75	-0.44	0.7	0.99	-0.93
Long Term Debt	-0.79	0.86	-0.96	-0.8	-0.82	1.0	-0.83	-0.53	-0.71	0.25	0.84	-0.59	-0.02	-0.82	-0.4	-0.89		-0.73	-0.76	-0.48	0.84	-0.63	0.53	-0.66	-0.92	0.82
Cash And Short Term Investments	0.98	-0.94	0.86	0.48	0.96	-0.73	0.92	0.6	0.48	-0.73	-0.68	0.89	0.53	0.91	0.52	0.83	-0.73		0.6	0.33	-0.9	0.56	-0.3	0.93	0.89	-0.93
Net Receivables	0.71	-0.79	0.65	0.88	0.8	-0.76	0.87	0.82	0.99	0.09	-0.99	0.66	-0.34	0.8	0.26	0.8	-0.76	0.6		0.76	-0.88	0.74	-0.87	0.43	0.82	-0.85
Common Stock Shares Outstanding	0.37	-0.42	0.39	0.43	0.48	-0.49	0.56	0.38	0.78	0.25	-0.73	0.35	-0.43	0.39	-0.01	0.31	-0.48	0.33	0.76		-0.56	0.34	-0.94	0.26	0.41	-0.52
Non Current Liabilities Total	-0.96	0.98	-0.86	-0.78	-0.99	0.84	-1.0	-0.8	-0.8	0.38	0.92	-0.87	-0.13	-0.97	-0.46	-0.93	0.84	-0.9	-0.88	-0.56		-0.74	0.61	-0.77	-0.97	1.0
Capital Lease Obligations	0.63	-0.67	0.62	0.81	0.68	-0.63	0.69	0.91	0.7	0.01	-0.79	0.8	-0.2	0.65	0.79	0.75	-0.63	0.56	0.74	0.34	-0.74		-0.4	0.23	0.75	-0.72
Inventory	-0.39	0.48	-0.37	-0.63	-0.51	0.53	-0.61	-0.51	-0.91	-0.35	0.81	-0.33	0.55	-0.49	0.1	-0.44	0.53	-0.3	-0.87	-0.94	0.61	-0.4		-0.22	-0.48	0.57
Other Current Assets	0.89	-0.84	0.78	0.29	0.85	-0.65	0.8	0.31	0.31	-0.82	-0.51	0.66	0.66	0.82	0.23	0.7	-0.66	0.93	0.43	0.26	-0.77	0.23	-0.22		0.76	-0.8
Other Stockholder Equity	0.95	-0.98	0.92	0.83	0.96	-0.92	0.96	0.75	0.74	-0.41	-0.88	0.82	0.17	0.97	0.51	0.99	-0.92	0.89	0.82	0.41	-0.97	0.75	-0.48	0.76		-0.96
Total Liab	-0.97	0.98	-0.86	-0.74	-1.0	0.83	-1.0	-0.79	-0.76	0.45	0.89	-0.89	-0.2	-0.98	-0.47	-0.93	0.82	-0.93	-0.85	-0.52	1.0	-0.72	0.57	-0.8	-0.96

Click cells to compare fundamentals

Sera Prognostics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether Sera Prognostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sera Prognostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sera Prognostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sera Prognostics Stock:

How To Invest In Sera

Details

Is Sera Stock a good investment?

Details

What is Sera Prognostics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sera Prognostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.

You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sera Prognostics. If investors know Sera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sera Prognostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.99)

Revenue Per Share

0.003

Quarterly Revenue Growth

(0.31)

Return On Assets

(0.27)

Return On Equity

(0.50)

The market value of Sera Prognostics is measured differently than its book value, which is the value of Sera that is recorded on the company's balance sheet. Investors also form their own opinion of Sera Prognostics' value that differs from its market value or its book value, called intrinsic value, which is Sera Prognostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sera Prognostics' market value can be influenced by many factors that don't directly affect Sera Prognostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sera Prognostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sera Prognostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sera Prognostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sera Capital Surpluse vs Net Working Capital Analysis

Capital Surpluse vs Net Working Capital

Capital Surpluse vs Net Working Capital Correlation Analysis

Correlation Coefficient

Capital Surpluse

Net Working Capital

Sera Prognostics fundamental ratios Correlations

Sera Prognostics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Other Liab
Total Liab	+ 1.0	Non Current Liabilities Total
Total Stockholder Equity	+ 0.99	Total Assets
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Net Receivables	+ 0.99	Current Deferred Revenue
Other Stockholder Equity	+ 0.99	Other Assets

Total Liab	- 1.0	Net Tangible Assets
Non Current Liabilities Total	- 1.0	Net Tangible Assets
Total Liab	- 1.0	Total Stockholder Equity
Net Receivables	- 0.99	Retained Earnings
Non Current Liabilities Total	- 0.99	Total Stockholder Equity
Non Current Assets Total	- 0.99	Short Long Term Debt Total